We are live on ! Find out more
BI

BVF Inc Portfolio holdings

AUM $3.14B
1-Year Est. Return 249.53%
This Fund
S&P 500
This Quarter Est. Return
-2.94%
1 Year Est. Return
+249.53%
3 Year Est. Return
+690.11%
5 Year Est. Return
+1,011.36%
10 Year Est. Return
+22,702.25%
AUM
$2.56B
AUM Growth
-$105M
Cap. Flow
+$128M
Cap. Flow %
4.99%
Top 10 Hldgs %
48.1%
Holding
79
New
9
Increased
20
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$66.5M
2
AMRN
Amarin Corp
AMRN
+$47.6M
3
WHWK
Whitehawk Therapeutics
WHWK
+$35M
4
TYRA icon
Tyra Biosciences
TYRA
+$32.4M
5
KYMR icon
Kymera Therapeutics
KYMR
+$31.9M

Top Sells

Rank Stock Value
1
MRUS
Merus
MRUS
+$156M
2
ARGX icon
argenx
ARGX
+$90.3M
3
RLAY icon
Relay Therapeutics
RLAY
+$29.9M
4
FBRX icon
Forte Biosciences
FBRX
+$19.9M
5
IMVT icon
Immunovant
IMVT
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 94.03%
2 Financials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REPL icon
26
Replimune Group
REPL
$913M
$27.5M 1.07%
926,529
+7,601
+0.8% +$247K
CTIC
27
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$26.3M 1.03%
8,929,690
– –
VIRX
28
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$24.8M 0.97%
3,094,174
– –
ACRS icon
29
Aclaris Therapeutics
ACRS
$728M
$24.7M 0.96%
1,373,044
+373,044
+37% +$5.98M
XENE icon
30
Xenon Pharmaceuticals
XENE
$6.11B
$24M 0.94%
1,571,778
– –
IMA
31
ImageneBio Inc
IMA
$63.7M
$23.1M 0.9%
152,673
+5,390
+4% +$783K
EPIX
32
DELISTED
ESSA Pharma
EPIX
$22.8M 0.89%
2,851,461
+399,900
+16% +$6.36M
OVID icon
33
Ovid Therapeutics
OVID
$420M
$22.3M 0.87%
6,631,051
– –
JANX icon
34
Janux Therapeutics
JANX
$918M
$22M 0.86%
1,017,314
-159,367
-14% -$4.59M
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$21.3M 0.83%
2,772,226
– –
CBIO
36
Crescent Biopharma
CBIO
$525M
$20.9M 0.82%
95,443
– –
CRNX icon
37
Crinetics Pharmaceuticals
CRNX
$8.86B
$20.1M 0.78%
953,879
+929,599
+3,829% +$19.4M
NGM
38
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$20.1M 0.78%
955,000
– –
DAWN
39
DELISTED
Day One Biopharmaceuticals
DAWN
$19.2M 0.75%
810,284
-108,691
-12% -$2.6M
MTEM
40
DELISTED
Molecular Templates, Inc.
MTEM
$19.2M 0.75%
190,440
– –
ALPN
41
DELISTED
Alpine Immune Sciences Inc
ALPN
$17M 0.66%
+1,589,495
New +$14.6M
CGEM icon
42
Cullinan Oncology
CGEM
$1.01B
$16.6M 0.65%
735,106
– –
GRTS
43
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$16.5M 0.64%
1,528,072
-298,422
-16% -$2.72M
CALA
44
DELISTED
Calithera Biosciences, Inc
CALA
$16.2M 0.63%
372,617
+7,650
+2% +$330K
CALT
45
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$16.2M 0.63%
750,000
– –
CFRX
46
DELISTED
ContraFect Corporation
CFRX
$16.1M 0.63%
49,654
– –
STRO icon
47
Sutro Biopharma
STRO
$404M
$15.6M 0.61%
82,683
– –
SLN
48
Silence Therapeutics
SLN
$524M
$14.4M 0.56%
666,666
– –
VRDN icon
49
Viridian Therapeutics
VRDN
$2.1B
$13.2M 0.52%
804,126
+454,045
+130% +$6.66M
COGT icon
50
Cogent Biosciences
COGT
$6.72B
$12.9M 0.5%
1,532,282
– –
1
2
3 4

Similar funds

GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return

BVF Inc's Q3 2021 Portfolio in Review

As of Q3 2021, BVF Inc held 79 positions worth $2.56B, down 3.9% from $2.67B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

BVF Inc deployed $128M of net new capital in Q3 2021, opening 9 new positions and adding to 20 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 1,119,733 shares worth $58.9M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 98% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was argenx, an estimated $90.3M trimmed.

  • BVF Inc's largest Q3 2021 buy was Lakefront Biotherapeutics American Depositary Shares: 1,119,733 shares worth $58.9M.
  • BVF Inc added most to Amarin Corp in Q3 2021, an estimated $47.6M increase.
  • BVF Inc's biggest Q3 2021 reduction was argenx, cutting an estimated $90.3M.
  • BVF Inc fully exited Merus in Q3 2021, selling an estimated $156M.
  • BVF Inc's ten largest holdings make up 48% of its $2.56B portfolio in Q3 2021.
  • BVF Inc opened 9 new positions and closed 4 in Q3 2021.
  • BVF Inc's portfolio value fell 3.9% quarter-over-quarter to $2.56B.

Based on BVF Inc's 13F filing for Q3 2021, filed 15 Nov 2021.